Super-enhancers (SEs) are large clusters of transcriptional regulatory elements that drive oncogene expression, maintain ...

Colorectal cancer is the third most commonly diagnosed cancer worldwide and the second leading cause of cancer death, yet one ...

While radiation therapy is an effective tool to destroy cancer cells, a new study from Vanderbilt researchers suggests that ...

A new study led by researchers at the Institute of Materials Science of Barcelona (ICMAB-CSIC) reveals why a particular boron ...

Mineral casts of cancer cell surfaces reprogram fat cells into stem cells and improve insulin sensitivity in obese mice ...

An octopus-shaped nanomachine hijacks tumor ATP leakage to power a self-amplifying cycle of membrane damage, drug delivery, and metabolic collapse in cancer cells.

Circulating tumor cells were first described in 1869 by Thomas Ashworth, an Australian pathologist who observed them in a peripheral blood sample taken from a patient with metastatic cancer. 1 They ...

Bristol Myers Squibb hasn’t had much luck with its efforts to develop cancer treatments called T cell engagers. But the pharmaceutical company isn’t done pursuing this type of targeted cancer therapy, ...

Researchers at the Université de Genève have built a DNA-based drug delivery system that reads pairs of protein markers on a ...

Claim: Miracle cures for cancer, including fasting, chanting mantras and homemade juice, kill cancer cells and cure cancer.

PRO-XTEN dual masking aims to keep the engager inactive in circulation, activate within tumor protease-rich microenvironments ...

The dedicated billing code, 0640U, effective July 1, 2026, establishes a unique reimbursement identifier for the CNSide CSF TCE test, supporting payer claims processing and facilitating broader ...